Canada markets closed

NLS Pharmaceutics AG (NLSP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.6200-0.0765 (-10.98%)
At close: 03:59PM EDT
0.6133 -0.01 (-1.08%)
After hours: 07:58PM EDT
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
2018-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
5,919
5,919
99.58
1,702
1,437
Selling General and Administrative
5,941
5,941
2,200
2,495
2,012
Total Operating Expenses
11,861
11,861
2,299
4,197
3,449
Operating Income or Loss
-11,861
-11,861
-2,299
-4,197
-3,449
Interest Expense
68.134
68.134
233.7
819.711
1,069
Total Other Income/Expenses Net
-17.323
-17.323
-328.365
-430.396
-629.232
Income Before Tax
-11,946
-11,946
-2,861
-5,447
-5,147
Income from Continuing Operations
-11,946
-11,946
-2,861
-5,447
-5,147
Net Income
-11,946
-11,946
-2,861
-5,447
-5,147
Net Income available to common shareholders
-11,946
-11,946
-2,861
-5,447
-5,147
Basic EPS
-
-
-0.27
-0.46
-0.44
Diluted EPS
-
-
-0.27
-0.46
-0.44
Basic Average Shares
-
-
11,779
11,779
11,779
Diluted Average Shares
-
-
11,779
11,779
11,779
EBITDA
-
-11,868
-2,628
-4,627
-4,078